|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Affinity Asset Advisors LLC
✚
|
|
|---|---|
| CRD # | 312788 |
| SEC # | 801-120744 |
| CIK # | 0001773195 |
| AUM | $807.9 M (2025-03-27) |
| Employees | 10 (70% Investors, 0% Brokers) |
| Phone | 646-481-3856 |
| Address | 450 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001773195 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Verona Pharma PLC | 57.7 | ||
| Insmed Inc | 47.8 | ||
| Xenon Pharmaceuticals Inc | 34.4 | ||
| Arcellx Inc | 32.6 | ||
| Nuvalent Inc | 31.7 | ||
| Apogee Therapeutics Inc | 30.2 | ||
| Alkermes PLC | 28.6 | ||
| Exelixis Inc | 26.4 | ||
| Protagonist Therapeutics Inc | 24.3 | ||
| Synta Pharmaceuticals Corp | 24.2 | ||
| Teva Pharmaceutical Industries Ltd | 23.5 | ||
| Lexeo Therapeutics Inc | 14.4 | ||
| Desert Gateway Inc | 14.4 | ||
| Establishment Labs Holdings Inc | 14.3 | ||
| Trevi Therapeutics Inc | 13.9 | ||
| Wave Life Sciences Ltd | 13.0 | ||
| Vera Therapeutics Inc | 12.8 | ||
| Mineralys Therapeutics Inc | 12.2 | ||
| Centessa Pharmaceuticals PLC | 11.8 | ||
| Amgen Inc | 11.2 | ||
| Nurix Therapeutics Inc | 11.0 | ||
| FITS My Style Inc | 9.8 | ||
| CRISPR Therapeutics AG | 9.7 | ||
| Ventyx Biosciences Inc | 9.7 | ||
| Aeglea Biotherapeutics Inc | 9.1 | ||
| Imara Inc | 8.0 | ||
| Proqr Therapeutics NV | 7.1 | ||
| Akebia Therapeutics Inc | 7.1 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| VC | Affinity Healthcare Special CT II LP | [2022-03-28] | 7.5 | 7.3 |
| HF | Affinity Healthcare Fund LP | [2021-03-09] | 269.1 | 807.9 |
| VC | Affinity Healthcare Special SG LP | [2021-03-09] | 2.2 | 3.5 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 807.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 807.9 |
| By Discretionary | ||
| Discretionary | 2 | 807.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 807.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 143.7 | |
| United States Persons | 664.2 | |
| Total | 2 | 807.9 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Jonathan Chu | 13 | ||
| Michael Cho | 5 | ||
| Affinity Asset Advisors LLC | 4 | ||
| Affinity Healthcare GP LLC | 2 | ||
| Affinity Healthcare Special GP II LLC | 1 | ||
| Affinity Healthcare Special GP LLC | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001773195] | |
| SC 13G | [0001773195] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Crow's Nest Holdings LP
✚
|
VA | 0.8 |
|
First Citizens Institutional Asset Management LLC
✚
|
NY | 0.8 |
|
Pinnbrook Capital Management LP
✚
|
NY | 0.8 |
|
Lykos Global Management LP
✚
|
CT | 0.8 |
|
Capeview Capital LLP
✚
|
0.8 | |
|
The Cypress Funds LLC
✚
|
CA | 0.8 |
|
Enhalus Capital LP
✚
|
NY | 0.8 |
|
BWCP LP
✚
|
TX | 0.8 |
|
Sciencast Management LP
✚
|
NJ | 0.8 |
|
JB Investments Management LLC
✚
|
0.8 |